These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3158278)

  • 1. Comparative activity of ciprofloxacin against anaerobic bacteria.
    Sutter VL; Kwok YY; Bulkacz J
    Antimicrob Agents Chemother; 1985 Mar; 27(3):427-8. PubMed ID: 3158278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.
    Whiting JL; Cheng N; Chow AW
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1379-82. PubMed ID: 3674848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
    Borobio MV; Perea EJ
    Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is ciprofloxacin active against clinically important anaerobes?
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of 9 beta-lactamines, clindamycin and metronidazole on strictly anaerobic bacteria].
    Derriennic M; Reynaud A; Launay C; Courtieu AL
    Pathol Biol (Paris); 1987 May; 35(5):572-6. PubMed ID: 3302862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).
    Prabhala RH; Rao B; Marshall R; Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1984 Nov; 26(5):785-6. PubMed ID: 6517561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic sensitivity testing of anaerobic bacteria by the breakpoint method.
    Höffler U; Pulverer G
    Chemotherapy; 1984; 30(6):392-7. PubMed ID: 6518836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of anaerobic bacteria to tosufloxacin.
    Nord CE; Lindmark A; Persson I; Runow C
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):263-5. PubMed ID: 1597207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of environmental factors on the in vitro efficacy of ciprofloxacin against anaerobic bacteria.
    Thadepalli H; Bansal MB; Marshall R; Prabhala RH
    Chemotherapy; 1989; 35(3):153-9. PubMed ID: 2766855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of L-627 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro activity of ciprofloxacin in combination with other agents against anaerobes of clinical interest.
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):679-80. PubMed ID: 2941405
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM; Finegold SM
    Antimicrob Agents Chemother; 1988 Apr; 32(4):601-4. PubMed ID: 3163908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1985 Apr; 27(4):657-9. PubMed ID: 3847273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.